Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • How Our Journey Began
    • News →
      • Latest News
      • Research News
      • Foundation News
      • Impact Reports
      • Newsletters
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery for Pancreatic Cancer
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • Seed Grant News
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • Catalyst Grant Program
        • Catalyst Grant Recipients
          • Evan Abt, PhD
          • Jason Link, PhD
          • Roger Lo, MD, PhD
      • UCLA Pancreas Tissue Bank
      • UC Pancreatic Cancer Consortium
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • PNET Pathway Grant Program
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Where to Begin
    • Caregivers & Families
    • Symposium →
      • Symposium Presentations
    • Patient & Family Webinars
    • Genetic Counseling
    • Resources →
      • NCCN Guidelines for Patients
      • Patient Support Tools
      • Create Your Health Care Team
      • Patient Health Diaries
      • Support Groups
      • Financial Aid
  • HOW YOU CAN HELP
    • Donate Now
    • Give in Tribute →
      • Create a Tribute Page
      • Search for Tribute Fund
    • Ways to Donate →
      • Monthly Giving
      • Donor-Advised Funds
      • Planned Giving
      • Matching Gifts
      • Car Program
    • Fundraise →
      • Purple Ribbon Fundraisers
      • Create a Tribute Page
      • Social Media
      • Fundraising Resources
      • Make Custom Shirts
      • Signature Events
    • Participate →
      • November Awareness Month →
        • World Pancreatic Cancer Day
      • Volunteer
      • Shop Online Store
      • Wedding Program
      • Awareness Resources
      • Signature Events
    • Event Calendar
    • Get Inspired
  • SEARCH
Home / About the Foundation / About Us / Scientific Advisory Board / Guido Eibl, MD

Guido Eibl, MD

  • Professor, Department of Surgery, UCLA
  • Director, Hirshberg Laboratory for Pancreatic Cancer Research

Mara Sherman

Dr. Guido Eibl is Professor in the Department of Surgery at the David Geffen School of Medicine at UCLA and since 2014 the Director of the Hirshberg Laboratory for Pancreatic Cancer Research at UCLA.

He received his Medical Degree from the Technical University in Munich, Germany, in 1996 and started his surgical residency at the Benjamin Franklin University Hospital in Berlin, Germany. In 2000 Dr. Guido Eibl began a postdoctoral fellowship in the Hirshberg Laboratory for Pancreatic Cancer Research in the Department of Surgery at UCLA under the mentorship of Drs. Howard Reber and Joe Hines. In 2004 he was appointed to the faculty as an Assistant Professor and in 2013 became full Professor in the Department of Surgery.

His research interest has initially been in the field of acute pancreatitis and since 2000 became the study of pancreatic cancer, in particular inflammatory processes in the pathogenesis of pancreatic cancer and the role of obesity in pancreatic cancer development and progression using mostly animal models of the disease. Dr. Guido Eibl’s research has been published in more than 100 peer reviewed manuscripts and funded by the National Cancer Institute with a cumulative award of more than 15 million dollars as the Principal Investigator. He has successfully led highly productive, multi-team research programs on pancreatic cancer for the past 15 years and continues to collaborate with other teams at UCLA and Cedars Sinai to find efficacious interventions to prevent or intercept pancreatic cancer development.

image_pdfimage_print

About the Foundation

  • Agi’s Story
  • About Us
    • Mission
    • Directors/Trustees
    • Scientific Advisory Board
    • How Our Journey Began
  • News
    • Latest News
    • Research News
    • Foundation News
    • Impact Reports
    • Newsletters
    • Press Room
  • Contact

Patient Support Resources

from the comfort of your home


Our Webinar Library »

Never Give Up.
The journey continues with an end in sight.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

Join Our E-newsletter

  • Legal and Privacy
  • Financial Information
  • Contact